3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
9
Ovarian Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Stomach Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Bites and Stings
1
Adenocarcinoma
1
Interventions
Carboplatin
42
Etoposide
37
Cisplatin
23
Topotecan
22
Nivolumab
17
pembrolizumab
12
atezolizumab
12
Ipilimumab
10
Paclitaxel
9
durvalumab
8
Irinotecan
8
Radiosurgery
6
Pemetrexed
6
rovalpituzumab tesirine
5
Magnetic Resonance Spectroscopy
5
trioctyl phosphine oxide
4
trilaciclib
4
etoposide phosphate
4
berzosertib
4
Sunitinib
4
Specimen Handling
4
Platinum
4
PM 01183
4
Dexamethasone
4
veliparib
3
tremelimumab
3
olaparib
3
carfilzomib
3
cabozantinib
3
Temozolomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Small Cell Lung Carcinoma
×
dostarlimab
×
Clear all
No trials found.